Studying the antibody repertoire after vaccination: Practical applications

Trends in Immunology

Volumn 35, Issue 7, 2014, Pages 319-331

  Galson, Jacob D ^a   Pollard, Andrew J ^a   Trück, Johannes ^a   Kelly, Dominic F ^a  

^a NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Antibody repertoire; B cell receptor repertoire; Immunoglobulin repertoire; Next generation sequencing; Vaccination; VDJ

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; VACCINE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; B LYMPHOCYTE; HUMAN; IMMUNOGENICITY; NONHUMAN; REVIEW; TECHNOLOGY; VACCINATION; ACTIVE IMMUNIZATION; ANIMAL; DRUG DEVELOPMENT; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOGLOBULIN GENE; IMMUNOLOGY;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; DRUG DISCOVERY; GENES, IMMUNOGLOBULIN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNITY, ACTIVE; VACCINATION; VACCINES;

EID: 84903527532     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.04.005     Document Type: Review

References (107)

1. Ehreth J. The global value of vaccination. Vaccine 2003, 21:596-600.
2. Boyd S.D., et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel V-D-J pyrosequencing. Sci. Transl. Med. 2009, 1:12ra23.
3. Arnaout R., et al. High-resolution description of antibody heavy-chain repertoires in humans. PLoS ONE 2011, 6:e22365.
4. Vollmers C., et al. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:13463-13468.
5. Glanville J., et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20216-20221.
6. Roux K.H. Immunoglobulin structure and function as revealed by electron microscopy. Int. Arch. Allergy Immunol. 1999, 120:85-99.
7. North B., et al. A new clustering of antibody CDR loop conformations. J. Mol. Biol. 2011, 406:228-256.
8. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
9. Victora G.D., Nussenzweig M.C. Germinal centers. Annu. Rev. Immunol. 2012, 30:429-457.
10. Shih H., Krangel M.S. Chromatin architecture, CCCTC-binding factor, and V(D)J recombination: managing long-distance relationships at antigen receptor loci. J. Immunol. 2013, 190:4915-4921.
11. Glanville J., et al. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20066-20071.
12. Wang C., et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J. Immunol. 2013, 192:603-611.
13. Wu Y-C.B., et al. Age-related changes in human peripheral blood IGH repertoire following vaccination. Front. Immunol. 2012, 3:193.
14. Ademokun A., et al. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011, 10:922-930.
15. Dunn-Walters D.K., Ademokun A.A. B cell repertoire and ageing. Curr. Opin. Immunol. 2010, 22:514-520.
16. Jiang N., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci. Transl. Med. 2013, 5:171ra19.
17. Boyd S.D., et al. Human lymphocyte repertoires in ageing. Curr. Opin. Immunol. 2013, 25:511-515.
18. Dekosky B.J., et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat. Biotechnol. 2013, 31:166-169.
19. Krause J.C., et al. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J. Immunol. 2011, 187:3704-3711.
20. Wrammert J., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
21. Tan Y-C., et al. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin. Immunol. 2014, 151:55-65.
22. Poulsen T.R., et al. Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. J. Immunol. 2011, 187:4229-4235.
23. Frölich D., et al. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J. Immunol. 2010, 185:3103-3110.
24. Adderson E., et al. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. J. Clin. Invest. 1993, 91:2734-2743.
25. Liu L., Lucas A.H. IGH V3-23*01 and its allele V3-23*03 differ in their capacity to form the canonical human antibody combining site specific for the capsular polysaccharide of Haemophilus influenzae type b. Immunogenetics 2003, 55:336-338.
26. Rohatgi S., et al. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation. J. Immunol. 2009, 182:5570-5585.
27. Wrammert J., et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181-193.
28. Yu X., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536.
29. Krause J.C., et al. Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J. Virol. 2012, 86:6334-6340.
30. Simmons C.P., et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 2007, 4:e178.
31. Whittle J.R.R., et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14216-14221.
32. Corti D., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.
33. Weitkamp J-H., et al. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J. Immunol. 2003, 171:4680-4688.
34. Weitkamp J-H., et al. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J. Immunol. Methods 2003, 275:223-237.
35. Weitkamp J-H., et al. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum. Immunol. 2005, 66:666-676.
36. Tian C., et al. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J. Immunol. 2008, 180:3279-3288.
37. Wu X., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011, 333:1593-1602.
38. Zhu J., et al. Somatic populations of PGT135-137 HIV-1-neutralizing antibodies identified by 454 pyrosequencing and bioinformatics. Front. Microbiol. 2012, 3:315.
39. Scheid J.F., et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636-640.
40. Zhu J., et al. Mining the antibodyome for HIV-1 - neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6470-6475.
41. Huang C., et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2706-2711.
42. Bonsignori M., et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 2011, 85:9998-10009.
43. Corti D., et al. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS ONE 2010, 5:e8805.
44. Scheid J.F., et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011, 333:1633-1637.
45. Racanelli V., et al. Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections. PLoS ONE 2011, 6:e25606.
46. Lu D.R., et al. Identification of functional anti-Staphylococcus aureus antibodies by sequencing patient plasmablast antibody repertoires. Clin. Immunol. 2014, 152:77-89.
47. Parameswaran P., et al. Convergent antibody signatures in human dengue. Cell Host Microbe 2013, 13:691-700.
48. Beltramello M., et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010, 8:271-283.
49. Smith S.A., et al. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol. 2012, 86:2665-2675.
50. De Alwis R., et al. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 2011, 5:e1188.
51. Dejnirattisai W., et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328:745-748.
52. Wine Y., et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2993-2998.
53. Awdeh Z.L., et al. Isoelectric focusing in polyacrylamide gel and its application to immunoglobulins. Nature 1968, 219:66-67.
54. Seidman J.G., et al. Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:3881-3885.
55. Adderson E.E., et al. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. 1991, 147:1667-1674.
56. Wilson P.C., Andrews S.F. Tools to therapeutically harness the human antibody response. Nat. Rev. Immunol. 2012, 12:709-719.
57. Wang X., Stollar B.D. Human immunoglobulin variable region gene analysis by single cell RT-PCR. J. Immunol. Methods 2000, 244:217-225.
58. Tiller T., et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 2008, 329:112-124.
59. Smith K., et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 2009, 4:372-384.
60. Lucas A.H., et al. Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect. Immun. 1994, 62:3873-3880.
61. Pinchuk G.V., et al. Predominant V-region gene configurations in the human antibody response to Haemophilus influenzae capsule polysaccharide. Scand. J. Immunol. 1995, 41:324-330.
62. Lucas A.H., Reason D.C. Polysaccharide vaccines as probes of antibody repertoires in man. Immunol. Rev. 1999, 171:89-104.
63. Weinstein J.A., et al. High-throughput sequencing of the zebrafish antibody repertoire. Science 2009, 324:807-810.
64. Boyd S.D., et al. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J. Immunol. 2010, 184:6986-6992.
65. Larimore K., McCormick M. Shaping of human germline IgH repertoires revealed by deep sequencing. J. Immunol. 2012, 189:3221-3230.
66. Benichou J., et al. The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. J. Immunol. 2013, 190:5567-5577.
67. Briney B.S., et al. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology 2012, 137:56-64.
68. Lavinder J.J., et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:2259-2264.
69. Zhu J., et al. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E4088-E4097.
70. von Büdingen H.C., et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J. Clin. Invest. 2012, 122:4533-4543.
71. Blanchard-Rohner G., et al. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 2009, 114:4998-5002.
72. Henn A.D., et al. High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature. Sci. Rep. 2013, 3:2327.
73. Mitchell R., et al. Polysaccharide-specific B cell responses to vaccination in humans. Hum. Vaccin. Immunother. 2014, 10:5-4.
74. Klein U., et al. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997, 89:1288-1298.
75. Keller M.A., Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 2000, 13:602-614.
76. Reddy S.T., et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat. Biotechnol. 2010, 28:965-969.
77. ®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology 2013, 218:745-754.
78. Xiao X., et al. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 2009, 390:404-409.
79. Kwong P.D., et al. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat. Rev. Immunol. 2013, 13:693-701.
80. Liao H-X., et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 2011, 208:2237-2249.
81. Liao H-X., et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013, 496:469-476.
82. Dimitrov D.S. Therapeutic antibodies, vaccines and antibodyomes. MAbs 2010, 2:347-356.
83. Sepúlveda N., et al. Estimation of T-cell repertoire diversity and clonal size distribution by Poisson abundance models. J. Immunol. Methods 2010, 353:124-137.
84. Wiley S.R., et al. Targeting TLRs expands the antibody repertoire in response to a malaria vaccine. Sci. Transl. Med. 2011, 3:93ra69.
85. Khurana S., et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 2011, 3:85ra48.
86. Li G-M., et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9047-9052.
87. Jilg W., et al. Vaccination against hepatitis B: comparison of three different vaccination schedules. J. Infect. Dis. 1989, 160:766-769.
88. Wu Y-C., et al. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 2010, 116:1070-1078.
89. Briney B.S., et al. High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals. Genes Immun. 2012, 13:469-473.
90. Mroczek E.S., et al. Differences in the composition of the human antibody repertoire by B cell subsets in the blood. Front. Immunol. 2014, 5:1-14.
91. Tarlinton D., Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility. Science 2013, 341:1205-1211.
92. Plotkin S.A. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 2008, 47:401-409.
93. Warren R., et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least of at least 1 million clonotypes. Genome Res. 2011, 21:790-797.
94. Perrett K.P., et al. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin. Infect. Dis. 2010, 50:1601-1610.
95. Rubelt F., et al. Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires. PLoS ONE 2012, 7:e49774.
96. Markle J.G., Fish E.N. SeXX matters in immunity. Trends Immunol. 2013, 35:97-104.
97. Shendure J., Ji H. Next-generation DNA sequencing. Nat. Biotechnol. 2008, 26:1135-1145.
98. Gao F., et al. Characterizing immunoglobulin repertoire from whole blood by a personal genome sequencer. PLoS ONE 2013, 8:e75294.
99. Bolotin D.A., et al. Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms. Eur. J. Immunol. 2012, 42:3073-3083.
100. Loman N.J., et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat. Biotechnol. 2012, 30:434-439.
101. Kolibab K., et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire. Infect. Immun. 2005, 73:7465-7476.
102. Laserson U., et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc. Natl. Acad. Sci. U.S.A. 2014, 10.1073/pnas.1323862111.
103. Benichou J., et al. Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology 2012, 135:183-191.
104. Baum P.D., et al. Wrestling with the repertoire: the promise and perils of next generation sequencing for antigen receptors. Eur. J. Immunol. 2012, 42:2834-2839.
105. Matsuda F., et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 1998, 188:2151-2162.
106. Zhu J., et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6470-6475.
107. Kidd B.A., et al. Unifying immunology with informatics and multiscale biology. Nat. Immunol. 2014, 15:118-127.